Is AnPac Bio-Medical Science Co., Ltd. (ANPC) a Buy, Sell, or Hold?
NASDAQ : ANPC
AnPac Bio-Medical Science Co., Ltd. — Institutional Ownership
$4.3 USD
-$0.14 (-3.15%)
- Volume
- 35.7K
- Average Volume
- 21.49K
- Market Capitalization
- $26.97M
- P/E Ratio
- -0.53
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $11.99
- Year Low
- $2.60
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $0.32
Institutional Ownership Summary
Institutional Ownership %
%
Investors Holding
change: 0.0 | last:
Increased Positions
change: 0.0 | last:
Reduced Positions
change: 0.0 | last:
New Positions
change: 0.0 | last:
Sold Positions
change: 0.0 | last:
Total Calls
-
Total Puts
-
Put-Call Ratio
change: 0.0 | last:
Total Invested
-
Beneficial Ownership Filings
| Filing Date | Reporting Person | Amount Beneficially Owned | % of Class |
|---|---|---|---|
| 2023-07-27 | Xu | 71.77M | 24.37% |
| 2023-07-27 | LLC | 66.33M | 22.53% |
| 2023-03-24 | ST. FORTUNE GROUP LLC | 14.21M | 12.81% |
| 2023-03-24 | Duo Liu | 14.21M | 12.81% |
| 2022-06-29 | CRS Holdings Inc. | 2.17M | 78.39% |
| 2022-06-29 | Chris Chang Yu | 2.17M | 78.39% |
| 2022-02-14 | CRS Holdings Inc. | 2.17M | 78.39% |
| 2022-02-14 | Chris Chang Yu | 365.96K | 2.69% |
| 2021-02-16 | CRS Holdings Inc. | 9800.0 | 0.11% |
| 2021-02-12 | Lei Luo | 70700.0 | 0.77% |
| 2021-02-12 | Zhijun Sihang Holding Limited | 606.7K | 6.60% |
| 2021-02-12 | Jiaxing Zhijun Sihang Investment Partnership Enterprises (Limited Partnership) | 606.7K | 6.60% |
| 2021-02-12 | Jiaxing Zhijun Investment Management Co., Ltd. | 606.7K | 6.60% |
| 2021-02-12 | Feng Guo | 606.7K | 6.60% |
| 2021-02-11 | Zhangjiang Gu Ke Company Ltd. | 859.2K | 9.35% |
| 2021-02-11 | He Yu | 1.21M | 10.06% |
| 2021-02-11 | Lin Ling | 859.2K | 9.35% |
ANPC Enterprise Value History
Annual
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2022-12-31 | $32.28 | 1.91M | $61.72M | $1.87M | $12.31M | $72.16M |
| 2021-12-31 | $154.99 | 680.28K | $105.44M | $9.25M | $33.76M | $129.94M |
| 2020-12-31 | $691.65 | 559.5K | $386.98M | $3.02M | $8.23M | $392.2M |
| 2019-12-31 | $1566.38 | 493.4K | $772.85M | $6.12M | $38.57M | $805.3M |
| 2018-12-31 | $1546.97 | 11.2M | $17.33B | $12.89M | $25.96M | $17.34B |
| 2017-12-31 | $1463.90 | 11.2M | $16.4B | $11.41M | $12.5M | $16.4B |
Quarterly
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2022-12-31 | $32.28 | 1.91M | $61.72M | $1.87M | $12.31M | $72.16M |
| 2022-09-30 | $21.77 | 1.45M | $31.52M | $7.58M | $8.82M | $32.77M |
| 2022-06-30 | $38.59 | 865.08K | $33.38M | $6.89M | $14.47M | $40.96M |
| 2022-03-31 | $55.66 | 865.08K | $48.15M | $462K | $18.83M | $66.52M |
| 2021-12-31 | $154.99 | 597.9K | $92.67M | $9.25M | $33.76M | $117.18M |
| 2021-09-30 | $417.74 | 11.96M | $5B | $5.46M | $30.01M | $5.02B |
| 2021-06-30 | $543.65 | 597.9K | $325.05M | $8.58M | $11.67M | $328.14M |
| 2021-03-31 | $785.00 | 597.9K | $469.35M | $9.02M | $22.38M | $482.71M |
| 2020-12-31 | $691.65 | 597.9K | $413.54M | $3.02M | $8.23M | $418.75M |
| 2020-09-30 | $507.94 | 597.9K | $303.7M | -$ | -$ | $303.7M |
| 2020-06-30 | $726.28 | 597.9K | $434.25M | $9.97M | $6M | $430.28M |
| 2020-03-31 | $1090.69 | 538.59K | $587.43M | -$ | -$ | $587.43M |